Jasper Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avidity Partners Management LP(5.1%),Avidity Partners Management (GP) LLC(5.1%), etc.
Jasper Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mahal Jeetinder Singh
Jasper Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Jasper Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Jasper Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jasper Therapeutics | 10-K: Annual report
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MARTELL RON
Jasper Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mahal Jeetinder Singh
Jasper Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer CROSS HERB
Jasper Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tucker Edwin Jonathan
Jasper Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Securities LLC(0.2%),Citadel Securities Group LP(0.2%), etc.
Jasper Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Qiming U.S. Healthcare Fund II, L.P.(6.2%),Qiming U.S. Healthcare GP II, LLC(6.2%), etc.
Jasper Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
Jasper Therapeutics | 4: Statement of changes in beneficial ownership of securities- Carlyle Group Inc.
Jasper Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Carlyle Group Inc.(7.1%),Carlyle Holdings I GP Inc.(7.1%), etc.
Jasper Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Velan Capital Investment Management LP
Jasper Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Velan Capital Investment Management LP(9.8%),Velan Capital Management LLC(9.8%), etc.
Jasper Therapeutics | 424B5: Prospectus
Jasper Therapeutics | 8-K: Current report
No Data